Main Article Content
Sickle cell, Sickle cell trait, Sickle cell disease, Sickle cell anemia, Haemoglobinopathies, Anemia, Hemolytic, Lebanon
Objectives: The objective of this study was to assess the prevalence, gender differences, and time trends of sickle cell trait in Beirut, Lebanon. Another objective was to describe a new screening technique for sickle cell trait carriers.
Methods: This was a retrospective cohort study carried out at a private laboratory in the southern suburb of Beirut, Lebanon between 2002 and 2014. The sickling test was carried out for each patient using two methods: the classical “sodium metabisulfite sickling test”, and the new “sickling test method” used in the private lab. As a confirmatory test, haemoglobin electrophoresis was run on a random sample of 223 cases who were found to be positive using the two sickling tests.
Results: A total of 899 cases were found to be positive for the sickle cell trait out of 184,105 subjects screened during the 12-year period, prevalence = 0.49% (95% CI: 0.46 – 0.52). Among the total sample, females were found to have higher prevalence, where no time trend over the studied period was noted. The haemoglobin electrophoresis method confirmed the results of this new sickling test technique among the random sample of the 223 cases.
Conclusion: We found that the prevalence of sickle cell trait is lower as compared to other Arab countries, higher in females, with no significant time trend. The sickle cell test was found to be an accurate, simple and cheap test which could be easily added as a requirement to the pre-marital testing to screen for sickle cell trait carriers.
2. Diallo, D. and G. Tchernia, Sickle cell disease in Africa. Curr Opin Hematol, 2002. 9(2): p. 111-6.
3. Modell, B. and M. Darlison, Global epidemiology of haemoglobin disorders and derived service indicators. Bull World Health Organ, 2008. 86(6): p. 480-7.
4. Okwi, A.L., et al., An up-date on the prevalence of sickle cell trait in Eastern and Western Uganda. BMC Blood Disord, 2010. 10: p. 5.
5. Bowers, A.S., D.J. Pepple, and H.L. Reid, Oxygen delivery index in subjects with normal haemoglobin (HbAA), sickle cell trait (HbAS) and homozygous sickle cell disease (HbSS). Clin Hemorheol Microcirc, 2008. 40(4): p. 303-9.
6. Stuart, M.J. and R.L. Nagel, Sickle-cell disease. Lancet, 2004. 364(9442): p. 1343-60.
7. World Health Organization. Fifty-ninth World Health Assembly: resolutions and decisions, annexes. WHA59/2006/REC/1. 2006.
8. Creary, M., D. Williamson, and R. Kulkarni, Sickle cell disease: current activities, public health implications, and future directions. J Womens Health (Larchmt), 2007. 16(5): p. 575-82.
9. Piel, F.B., et al., Global burden of sickle cell anaemia in children under five, 2010-2050: modelling based on demographics, excess mortality, and interventions. PLoS Med, 2013. 10(7): p. e1001484.
10. Kato, G.J., M.T. Gladwin, and M.H. Steinberg, Deconstructing sickle cell disease: reappraisal of the role of hemolysis in the development of clinical subphenotypes. Blood Rev, 2007. 21(1): p. 37-47.
11. Tsaras, G., et al., Complications associated with sickle cell trait: a brief narrative review. Am J Med, 2009. 122(6): p. 507-12.
12. Ansong, D., et al., Sickle cell disease: management options and challenges in developing countries. Mediterr J Hematol Infect Dis, 2013. 5(1): p. e2013062.
13. Ndefo, U.A., et al., Pharmacological management of sickle cell disease. P T, 2008. 33(4): p. 238-43.
14. Eichner, E.R., Sickle cell trait. J Sport Rehabil, 2007. 16(3): p. 197-203.
15. Ahmed, S.G. and U.A. Ibrahim, Haemoglobin-S in sickle cell trait with papillary necrosis. Br J Haematol, 2006. 135(3): p. 415-6.
16. Lopez Revuelta, K. and M.P. Ricard Andres, Kidney abnormalities in sickle cell disease. Nefrologia, 2011. 31(5): p. 591-601.
17. Li, E.J. and V.G. Carroll, Sickle cell trait and renal papillary necrosis. Clin Pediatr (Phila), 2014. 53(10): p. 1013-5.
18. Bencaiova, G., A. Krafft, and C. Breymann, Sickle cell trait and urinary tract infection in pregnancy. Int J Gynaecol Obstet, 2006. 92(2): p. 128-9.
19. Goodman, J., et al., The splenic syndrome in individuals with sickle cell trait. High Alt Med Biol, 2014. 15(4): p. 468-71.
20. Connes, P., et al., Blood rheology abnormalities and vascular cell adhesion mechanisms in sickle cell trait carriers during exercise. Clin Hemorheol Microcirc, 2008. 39(1-4): p. 179-84.
21. Humphreys, J.V., The management of sickle cell disease in a primary care setting. J Family Med Prim Care, 2012. 1(1): p. 56-8.
22. Kotila, T.R., Guidelines for the diagnosis of the haemoglobinopathies in Nigeria. Ann Ib Postgrad Med, 2010. 8(1): p. 25-9.
23. Y. Daniel, Practical Management of Haemoglobinopathies. Haemoglobinopathy diagnostic tests: blood counts, sickle solubility test, haemoglobin electrophoresis and high-performance liquid chromatography 2004: Blackwell Publishing.
24. Johns Hopkins Medicine. Sickle Cell Disease. 2014; Available from: http://m.hopkinsmedicine.org/healthlibrary/conditions/hematology_and_blood_disorders/sickle_cell_disease_85%2cP00101/.
25. Khoriaty, E., et al., Incidence of sickle cell disease and other hemoglobin variants in 10,095 lebanese neonates. PLoS One, 2014. 9(9): p. e105109.
26. Ojodu, J., et al., Incidence of sickle cell trait--United States, 2010. MMWR Morb Mortal Wkly Rep, 2014. 63(49): p. 1155-8.
27. Ballardini, E., et al., Universal neonatal screening for sickle cell disease and other haemoglobinopathies in Ferrara, Italy. Blood Transfus, 2013. 11(2): p. 245-9.
28. Botler, J., L.A. Camacho, and M.M. Cruz, Phenylketonuria, congenital hypothyroidism and haemoglobinopathies: public health issues for a Brazilian newborn screening program. Cad Saude Publica, 2012. 28(9): p. 1623-31.
29. Guler, E., et al., Prevalence of beta-thalassemia and sickle cell anemia trait in premarital screening in Konya urban area, Turkey. J Pediatr Hematol Oncol, 2007. 29(11): p. 783-5.
30. Jastaniah, W., Epidemiology of sickle cell disease in Saudi Arabia. Ann Saudi Med, 2011. 31(3): p. 289-93.
31. FJ, A., Prevalence of hemoglobinopathies among candidates attending premarital counseling in Bahrain. J of Bahrain Med Soc, 2008. 20: 145-149.
32. Hassan, M.K., et al., Frequency of haemoglobinopathies and glucose-6-phosphate dehydrogenase deficiency in Basra. East Mediterr Health J, 2003. 9(1-2): p. 45-54.
33. Hamamy, H., et al., Jordan: communities and community genetics. Community Genet, 2007. 10(1): p. 52-60.
34. Jain, R.C., Sickle cell and thalassaemic genes in Libya. Trans R Soc Trop Med Hyg, 1985. 79(1): p. 132-3.
35. Fattoum, S., [Hemoglobinopathies in Tunisia. An updated review of the epidemiologic and molecular data]. Tunis Med, 2006. 84(11): p. 687-96.
36. Al Hosani, H., et al., Incidence of haemoglobinopathies detected through neonatal screening in the United Arab Emirates. East Mediterr Health J, 2005. 11(3): p. 300-7.
37. Al-Nood, H., et al., Prevalence of the sickle cell gene in Yemen: a pilot study. Hemoglobin, 2004. 28(4): p. 305-15.
38. Kamble, M. and P. Chatruvedi, Epidemiology of sickle cell disease in a rural hospital of central India. Indian Pediatr, 2000. 37(4): p. 391-6.
39. Tripette, J., et al., Red blood cell aggregation, aggregate strength and oxygen transport potential of blood are abnormal in both homozygous sickle cell anemia and sickle-hemoglobin C disease. Haematologica, 2009. 94(8): p. 1060-5.
40. Dangi, C.B., et al., Sickle cell hemoglobinopathies in district Bhopal. Indian J Hum Genet, 2010. 16(2): p. 100-2.